Today's Heart Failure Clinic: A Modern Approach

UCLA Health

A. Ucla Cardiomyopathy Center

Real Time Physiological Data Analysis: Predicting Outcomes in Congen…

The Texas Heart Institute

E. Vu

Coarctation of the Aorta: What Are the Current Dilemmas in Prenatal …

CSI Education

G. Sharland, S. Qureshi, N. Rao Koneti

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Characteristics and Long Term Outcomes in Adults with Marfan Syndrom…

Cleveland Clinic Heart, Vascular and Thoracic Institute

L. Svensson, M. Desai

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Cardiac Surgery Case: Post Cardiotomy Shock Requiring Mechanical Cir…

The 10th Annual Western New England Acute Cardiology Conference

K. Wanamaker

Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…

UChicago Medicine

S. Nathan

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

What Should Our Goals Be in Treating Hypertension, and How Can We Be…

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

J. H. Ix

SCAD Case: How to Manage It

Scottsdale Interventional Forum 2022

D. A. Cox

Cardiogenic Shock: All Mechanical Circulatory Support Devices

Complex Coronary Cases

G. Serrao

Protected PCI for Complete Revascularization

Texas Cardiovascular Innovations Conference 2021

H. Nguyen